MetaCap

Propanc Biopharma (PPCB) vs Sunshine Biopharma (SBFM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Propanc Biopharma is the larger company by market cap ($1.9 million vs $1.8 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PPCB+256.93%SBFM+218.57%
+411%+154%-102%
Oct 7, 20261 yearNov 20, 2026
PPCB+266.48%SBFM+560.15%
+809%+356%-97%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PPCB versus SBFM key metrics
MetricPPCBSBFM
Share price$1.78$2.23
Market cap$1.87M$1.84M
1-day change+3.19%-5.11%
Forward P/E—0.01
EPS (TTM)$-95.92$-620.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$36.31M
Revenue growth (YoY)—+4.11%
Net income (latest FY)$-18.86M$-5.98M
Gross margin—33.76%
Operating margin—-17.15%
Net margin—-16.46%
52-week high$315.00$464.00
52-week low$1.61$2.23
Distance from 52-week high-99.43%-99.52%
Analyst consensus—none
Avg. price target upside—+2411.21%
Average volume188.66K301.48K
Shares outstanding1.05M823.77K
Employees250
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Propanc Biopharma

PPCB stock →

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

About Sunshine Biopharma

SBFM stock →

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 50 employees

PPCB vs SBFM FAQ

Which is bigger, Propanc Biopharma or Sunshine Biopharma?

Propanc Biopharma (PPCB) is larger, with a market capitalization of $1.87M compared with $1.84M for Sunshine Biopharma (SBFM).

Are Propanc Biopharma and Sunshine Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons